Evidence map›Paper›PMID 25901353›Full record

ArticlePloS one2015

Disentangling multidimensional spatio-temporal data into their common and aberrant responses.

Young Hwan Chang, James Korkola, Dhara N Amin, Mark M Moasser, Jose M Carmena, Joe W Gray, Claire J Tomlin

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Young Hwan ChangDepartment of Electrical Engineering and Computer Sciences, University of California, Berkeley, CA, USA.
James KorkolaDepartment of Biomedical Engineering and the Center for Spatial Systems Biomedicine, Oregon Health and Science University, Portland, OR, USA.
Dhara N AminDepartment of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.
Mark M MoasserDepartment of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.
Jose M CarmenaDepartment of Electrical Engineering and Computer Sciences, Helen Wills Neuroscience Institute, University of California, Berkeley and UCB/UCSF Graduate Program in Bioengineering, CA, USA.
Joe W GrayDepartment of Biomedical Engineering and the Center for Spatial Systems Biomedicine, Oregon Health and Science University, Portland, OR, USA.
Claire J TomlinDepartment of Electrical Engineering and Computer Sciences, University of California, Berkeley, CA, USA; Faculty Scientist, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.

Funding

Systems-Based Predictions of Responses to Cancer TherapyU54CA112970 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI GRAY, JOE W. · 2004 to 2014
$27.1M
TRAINING & OUTREACH COREP50GM107615 · NIGMS · STANFORD UNIVERSITY · PI COVERT, MARKUS W · 2013 to 2017
$10.9M
NCI NIH HHS 5U54CA112970-08NCI NIH HHS U54 CA112970
6 · The paper itself

Abstract

With the advent of high-throughput measurement techniques, scientists and engineers are starting to grapple with massive data sets and encountering challenges with how to organize, process and extract information into meaningful structures. Multidimensional spatio-temporal biological data sets such as time series gene expression with various perturbations over different cell lines, or neural spike trains across many experimental trials, have the potential to acquire insight about the dynamic behavior of the system. For this potential to be realized, we need a suitable representation to understand the data. A general question is how to organize the observed data into meaningful structures and how to find an appropriate similarity measure. A natural way of viewing these complex high dimensional data sets is to examine and analyze the large-scale features and then to focus on the interesting details. Since the wide range of experiments and unknown complexity of the underlying system contribute to the heterogeneity of biological data, we develop a new method by proposing an extension of Robust Principal Component Analysis (RPCA), which models common variations across multiple experiments as the lowrank component and anomalies across these experiments as the sparse component. We show that the proposed method is able to find distinct subtypes and classify data sets in a robust way without any prior knowledge by separating these common responses and abnormal responses. Thus, the proposed method provides us a new representation of these data sets which has the potential to help users acquire new insight from data.

Indexed as

AlgorithmsGene Regulatory NetworksNeural Networks, ComputerBiomarkers, TumorBreast NeoplasmsFemaleGene Expression Regulation, NeoplasticHumansLapatinibMutationPrincipal Component AnalysisProtein Array AnalysisProto-Oncogene Proteins c-aktQuinazolinesBiomarkers, TumorLapatinibProto-Oncogene Proteins c-aktQuinazolines

Identifiers

PMID25901353
PMCPMC4406848

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.